Status:
COMPLETED
An Open Study for Steroid Resistant, Non-Thymectomized MG Patients
Lead Sponsor:
Astellas Pharma Inc
Conditions:
Myasthenia Gravis
Eligibility:
All Genders
16-64 years
Phase:
PHASE3
Brief Summary
The purpose of the study is to investigate the efficacy and safety for steroid resistant, non-thymectomized MG patients.
Eligibility Criteria
Inclusion
- Clinically diagnosed as myasthenia gravis
- Those whose MG symptoms are not controlled by the treatment with prednisone
Exclusion
- Those who had undergone thymectomy
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00309101
Start Date
February 1 2006
End Date
February 1 2009
Last Update
June 3 2009
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Chubu Region, Japan
2
Chugoku Region, Japan
3
Hokkaido Region, Japan
4
Hokuriku Region, Japan